Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2008
08/14/2008CA2677347A1 Stable pharmaceutical drug aerosols
08/14/2008CA2677322A1 Complementary personal lubricant compositions and delivery system
08/14/2008CA2677310A1 Methods for treating diseases of altered ige regulation
08/14/2008CA2677292A1 Packaged product combination
08/14/2008CA2676975A1 Increased effectiveness of allylamine drug compounds
08/14/2008CA2676232A1 Dermatological emulsion and method for the preparation thereof
08/14/2008CA2676081A1 Solvating system and sealant for medical use
08/14/2008CA2674742A1 Free-flowing gelatin composition
08/13/2008EP1956082A1 Reversibly inactivated acidified plasmin
08/13/2008EP1955709A2 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines
08/13/2008EP1955695A1 Nanocapsules of lipophilic complexes of nucleic acids
08/13/2008EP1955694A1 HFC solution formulations containing an anticholinergic
08/13/2008EP1955693A1 Composition comprising chitosan and an acidic drug for oral controlled release
08/13/2008EP1955689A1 Positioning feature for aiding use of film or strip product
08/13/2008EP1955687A1 Packaged product mix
08/13/2008EP1955665A2 Embolic devices capable of in-situ reinforcement
08/13/2008EP1955597A1 Premix emulsion
08/13/2008EP1955069A2 Methods and kits for detecting fungal infection
08/13/2008EP1954770A1 Aqueous film coating composition containing sodium alginate and preparation thereof
08/13/2008EP1954315A2 Use of oligouronates for treating mucus hyperviscosity
08/13/2008EP1954282A2 Novel process and formulations
08/13/2008EP1954275A2 Pharmaceutical compositions comprising buprenorphine
08/13/2008EP1954267A1 Organic compounds comprising a glycopyrronium salt
08/13/2008EP1954266A1 Organic compounds comprising a glycopyrrolium salt
08/13/2008EP1954253A1 Nanoparticulate and controlled release compositions comprising cefditoren
08/13/2008EP1954252A2 Nanoparticles for use in immunogenic compositions
08/13/2008EP1954251A1 Slow-release composition, method for the preparation thereof and use of the same
08/13/2008EP1954248A2 Cosmetic skincare applications employing mineral-derived tubules for controlled release
08/13/2008EP1954247A1 Pharmaceutical compositions
08/13/2008EP1954245A2 Compositions of lipoxygenase inhibitors
08/13/2008EP1954244A1 Lyophilization process and products obtained thereby
08/13/2008EP1954243A2 A method for preparing liposomes and uses thereof
08/13/2008EP1954242A1 Orally absorbed pharmaceutical formulation and method of administration
08/13/2008EP1954241A1 Sustained-release formulation of zonisamide
08/13/2008EP1954240A2 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
08/13/2008EP1811981B1 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
08/13/2008EP1791530B1 Psychostimulant containing pharmaceutical composition
08/13/2008EP1746981B1 Medicinal aerosol formulation products with improved chemical stability
08/13/2008EP1740164B1 Statins for the treatment of ocular hypertension and glaucoma
08/13/2008EP1660054B1 Agent containing ergolin for transdermal application
08/13/2008EP1648374A4 Cosmetic compositions comprising a structuring agent, silicone powder and swelling agent
08/13/2008EP1610765B1 Non-aqueous single phase vehicles and formulations utilizing such vehicles
08/13/2008EP1603532B1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
08/13/2008EP1589949B1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
08/13/2008EP1567193B1 Colon cleansing compositions
08/13/2008EP1463801B1 Transdifferentiation of pancreatic acinar cells
08/13/2008EP1461042B1 Use of desoxypeganine for treating clinical depression
08/13/2008EP1435945B1 Topical migraine therapy
08/13/2008EP1435874B1 Implantable devices for treatment of pain by delivery of fentanyl and fentanyl congeners
08/13/2008EP1429914B1 Apparatus for manufacturing dosage forms
08/13/2008EP1389098B1 Delivery of antipsychotics through an inhalation route
08/13/2008EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route
08/13/2008EP1339282B1 Hydrophilic polymer blends used for dry cow therapy
08/13/2008EP1331924B1 Use of beta-carotene and lycopene for treating ageing symptoms via the inhibition of the expression of the metalloproteinase of type 1 of the extracellular matrix
08/13/2008EP1313415B1 Devices for intraocular drug delivery
08/13/2008EP1251835B1 Closure of bacterial ghosts
08/13/2008EP1181023B1 Compositions of polyacids, non-ionic polymers consisting of alkylene oxide monomers and multivalent cations and their use in reducing adhesions
08/13/2008EP1154759B1 Dispersible concentrate for the delivery of cyclosporin
08/13/2008EP1143939B1 Therapeutic system containing an active substance for the application on the skin which contains three polymerous layers
08/13/2008EP1117736B2 Modified starch film compositions
08/13/2008EP1082029B1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
08/13/2008EP1014805B1 Chewing gum containing physiological cooling agents
08/13/2008EP0936913B1 Oral pharmaceutical preparation containing ibandronat
08/13/2008CN201098374Y Medical plaster for treating stomach disease
08/13/2008CN201098252Y Traditional Chinese medicine bone fracture ironing therapeutic device
08/13/2008CN101243130A Compositions exhibiting improved flowability
08/13/2008CN101243094A Water-soluble metal alcoholate derivative, process for production of the derivative, and solid gelatinous agent for external application comprising the derivative
08/13/2008CN101242875A Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
08/13/2008CN101242856A Sustained drug release compositions
08/13/2008CN101242841A Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof
08/13/2008CN101242840A Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof
08/13/2008CN101242825A Use of L-carnitine and/or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
08/13/2008CN101242815A Device, system, and method comprising microencapsulated proton donor for release of nitric oxide from a polymer
08/13/2008CN101242814A Particles comprising a releasable dopant therein
08/13/2008CN101242813A Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds
08/13/2008CN101242812A Pancreatin micropellets suitable for enteric coating
08/13/2008CN101242811A Controlled release pharmaceutical compositions for acid labile drugs
08/13/2008CN101242810A Nanoparticulate megestrol formulations
08/13/2008CN101242809A Process
08/13/2008CN101242808A Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant
08/13/2008CN101242807A Mouth-moistening compositions, delivery systems containing same and methods of making same
08/13/2008CN101241788A Biological compatibility magnetic nano crystal for high dissolving and stable distribution in physiologicalbuffer liquid and its making method
08/13/2008CN101240032A Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
08/13/2008CN101240031A Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
08/13/2008CN101240030A Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240029A Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application
08/13/2008CN101240028A Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240027A Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240026A Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240017A A uro-genital disease treatment system
08/13/2008CN101240006A Oleanane triterpene compound with C ring containing conjugated double bond and use thereof
08/13/2008CN101240002A Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof
08/13/2008CN101239996A Method for preparing high shearing force microcrystal lactose
08/13/2008CN101239925A Method for preparing magnesium aspartate
08/13/2008CN101239198A Thin aqueous cataplasm
08/13/2008CN101239188A Method for improving chemical stability of biological collagen to antibiotic medicine
08/13/2008CN101239179A Non-aqueous polar aprotic peptide formulations
08/13/2008CN101239177A Chinese medicinal composition for curing alopecia, generating hair and blackening hair and its manufacturing method
08/13/2008CN101239176A í«Shunqi Daotaní» oral preparation and preparation thereof
08/13/2008CN101239175A Lung comforting plaster and preparation thereof
1 ... 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 ... 2991